Variables | Total No. (%) |
Age (mean ± SD) | 52.8 ± 14.4 |
Gender Male Female |
20 (55.6%) 16 (44.4%) |
Mode of presentation Primary Primary + metastases Recurrence Recurrence + metastases Metastases N/A |
22 (61.1%) 8 (22.2%) 3 (8.3%) 1 (2.8%) 1 (2.8%) 1 (2.8%) |
Site of involvement Stomach Small intestine Colorectal Omentum Retroperitoneal Hepatic Pelviabdominal N/A |
10 (27.8%) 7 (19.4%) 6 (16.7%) 4 (11.1%) 3 (8.3%) 1 (2.8%) 4 (11.1%) 1 (2.8%) |
Histopathology Spindle cells Epithelioid cells Mixed N/A |
23 (63.9%) 7 (19.4%) 5 (13.9%) 1 (2.8%) |
Tumour size ≤2 >2 - 5 >5 - 10 >10 |
1 (2.8%) 4 (11.15%) 11 (30.6%) 20 (55.6%) |
Mitotic count per 50 HPF ≤ 5 5 - 10 >10 N/A |
11 (30.6%) 14 (38.9%) 3 (5.6%) 9 (25%) |
c-kit immunoreactivity Negative Positive N/A |
8 (22.2%) 21 (58.3%) 7 (19.4%) |